How May LUCENTIS Help People With Macular Edema Following RVO?

Results from 2 studies showed:

LUCENTIS may help people with macular edema following RVO see more letters on an eye chart.

In a 6-month study of 263 people with macular edema following RVO:
Eye chart test comparison of retinal vein occlusion patients who received LUCENTIS® (ranibizumab injection) vs people who did not
In another 6-month study of 260 people with macular edema following RVO:
Eye chart test comparison of RVO patients who received LUCENTIS® (ranibizumab injection) vs people who did not

LUCENTIS may help improve* vision in people with macular edema following RVO

*Improvement means that they were able to see 15 or more letters on an eye chart.

In a 6-month study of 263 people with macular edema following RVO:

LUCENTIS MONTHLY


61% of 132 people saw an improvement*

NO LUCENTIS


29% of 131 people saw an improvement*

*This means they were able to read 15 or more letters on an eye chart

In another 6-month study of 260 people with macular edema following RVO:

LUCENTIS MONTHLY


48% of 130 people saw an improvement*

NO LUCENTIS


17% of 130 people saw an improvement*

*This means they were able to read 15 or more letters on an eye chart


Financial Assistance Options

Financial Assistance Options

There may be options to help you afford LUCENTIS, no matter what type of health insurance you have. Learn about Genentech Access Solutions.

Who is LUCENTIS for? LUCENTIS® is a prescription medicine for the treatment of patients with macular edema following retinal vein occlusion (RVO).

What important safety information should I know about LUCENTIS? You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. LUCENTIS is not for everyone. Some LUCENTIS patients have had detached retinas and serious eye infections. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. 

Some patients have had increased eye pressure before and within 1 hour of an injection. Your eye doctor should check your eye pressure and eye health before and after your LUCENTIS injection. 

Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. 

Some LUCENTIS patients have serious side effects related to the injection. These include serious infections inside the eye, detached retinas, and cataracts. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, anemia, nausea and cough. 

LUCENTIS is for prescription use only.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

For additional Safety Information, please talk to your doctor and see the LUCENTIS full Prescribing Information.